Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL448049 | 0.85 | ADRA2A (0.41) | HTR2CCYP1A2TSHRADRA2AADRA1A | |
| SCHEMBL9911950 | 0.85 | HTR2C (0.51) | KDM4ELMNAHTR2CGABRR1CYP1A2 | |
| Hydrochloric Acid SCHEMBL4158426 | 0.84 | KDM4E (0.52) | KDM4ELMNAHTR2CGABRR1CYP1A2 | |
| SCHEMBL2266822 | 0.84 | — | — | |
| SCHEMBL21416131 | 0.84 | — | — | |
| SCHEMBL28202831 | 0.84 | — | — | |
| SCHEMBL9911954 | 0.82 | HTR2C (0.53) | KDM4ELMNAHTR2CGABRR1CYP1A2 | |
| Hydrochloric Acid SCHEMBL4143640 | 0.81 | HTR2C (0.51) | KDM4ELMNAHTR2CGABRR1CYP1A2 | |
| Hydrochloric Acid SCHEMBL15562562 | 0.80 | LMNA (0.47) | KDM4ELMNAHTR2CGABRR1TSHR | |
| SCHEMBL28832991 | 0.80 | TSHR (0.35) | HTR2CTSHRADRA2AADRA1AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8198325-B2 | Unsaturated alkyl esters of 5-aminolevulinic acid, their preparation and their use | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2012-06-12 | — | — | US | disclosed |
| US-20090176881-A1 | Unsaturated Alkyl Esters of 5-Aminolevulinic Acid, their Preparation and their Use | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176881-A1 | Unsaturated Alkyl Esters of 5-Aminolevulinic Acid, their Preparation and their Use | ALAD, ALOX5, SLC7A1 | KDM4E 2283/4885LMNA 2675/4885HTR2C 1116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.